Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding an anthracycline to adjuvant chemotherapy for TOP2A-normal early breast cancer significantly improved disease ...

Early disease detection is beneficial for securing the best possible outcomes for patients. But finding noninvasive, ...

CHICAGO, IL—Taking sacubitril/valsartan (Entresto; Novartis) can help protect against the cardiotoxicity posed by anthracycline chemotherapy for high-risk patients with cancer, results from the ...

Considering taking supplements to treat anthracycline cardiotoxicity? Below is a list of common natural remedies used to treat or reduce the symptoms of anthracycline cardiotoxicity. Follow the ...

December 3, 2024) Early disease detection is beneficial for securing the best possible outcomes for patients. But finding ...

CNS Pharmaceuticals (CNSP) announced the presentation of updated results from the on-going potentially pivotal study evaluating Berubicin, the ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

Lete-cel is being investigated for the treatment of synovial sarcoma and myxoid/round cell liposarcoma (MRCLS) in the pivotal IGNYTE-ESO (NCT03967223) trial in patients who received prior ...